Anthropic found something in DNA. Nobody knows what it does.
Anthropic announced that Claude autonomously identified a new CRISPR-like enzyme system — a genuine first from its newly launched biology lab. The announcement is also, by CEO Dario Amodei's own admission, a discovery without a known function. Three outlets covered the announcement; none had independent scientific assessment of the claim. The most important sentence in the story came from Anthropic itself: they don't know what they found.
Anthropic's Claude AI Makes Significant Discovery in DNA Research
3 sources · hover a dot to see coverage
What happened
Anthropic announced that its AI model Claude autonomously discovered a new enzyme system it is comparing to CRISPR, the gene-editing machinery that reshaped modern biology. The discovery is described as the first result from Anthropic's recently launched biology lab. CEO Dario Amodei acknowledged publicly that the function of the enzyme system is not yet understood. No peer-reviewed findings were cited in any coverage. The Verge noted the lab itself is newly launched. Three outlets reported the announcement, all drawing from Anthropic's own characterization of the find. That is the wire version. What separates the coverage is thin — because the coverage itself is thin.
Decrypt was the only outlet to name the knowledge gap in its headline
Decrypt's headline — 'Anthropic Says Claude Found Something Big in DNA. It Just Doesn't Know What' — is the only one of the three that treats Amodei's admission as the story rather than the announcement. TechCrunch and The Verge both led with the discovery framing: 'found something big' and 'made a discovery it's comparing to Crispr.' Neither headline signals that the function of the enzyme system is unknown. Decrypt put the uncertainty in the lede. The other two buried it, if they included it at all.
What one side told you that the other didn't
No outlet sought independent scientific assessment of the claim.
All three outlets reported Anthropic's characterization of its own discovery without a named biologist, geneticist, or CRISPR researcher evaluating it. Comparing an enzyme system to CRISPR is a significant scientific claim. The Verge noted the lab is newly launched; TechCrunch called it 'something big' in its headline. Neither qualifier substitutes for external scrutiny. A press release about an unknown biological mechanism, unreviewed and unverified, is a PR announcement. That is what all three outlets ran.
The discovery has no known function. Most headlines don't say so.
Amodei's admission that nobody knows what the enzyme system does is the most consequential fact in the story. Decrypt made it the headline. TechCrunch and The Verge framed the story as a lab milestone. A reader who saw only those two headlines would walk away thinking Anthropic's biology lab had produced a meaningful scientific result. They would not know the result is, by the company's own description, a thing of unknown purpose.
What to watch
If Anthropic submits findings to a peer-reviewed journal or posts a preprint within the next 60 days, coverage will have to reckon with whether the enzyme system claim holds up to external review. If no publication follows, the announcement will stand as a marketing moment for the biology lab launch with no scientific corroboration on record.
This kind of gap — where one side reports a fact and the other doesn’t mention it — shows up in about 40% of major stories.